Relapsed/refractory Burkitt lymphoma and HIV infection

The care of patients with HIV and Burkitt lymphoma poses a challenge to clinicians. Due to the limited treatment options that exist for relapsed/refractory Burkitt lymphoma, there is a need for the development of new therapies. This review aims to discuss evidence for current management strategies i...

Full description

Saved in:
Bibliographic Details
Published in:International Journal of STD & AIDS 2018-06, Vol.29 (7), p.695-703
Main Authors: Khan, Alina, Brahim, Amanda, Ruiz, Marco, Nagovski, Neil
Format: Article
Language:English
Subjects:
AIDS/HIV
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Burkitt Lymphoma - etiology
Burkitt Lymphoma - therapy
Hematopoietic Stem Cell Transplantation - methods
HIV Infections - complications
HIV Infections - drug therapy
Humans
Neoplasm Recurrence, Local
Transplantation, Homologous
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The care of patients with HIV and Burkitt lymphoma poses a challenge to clinicians. Due to the limited treatment options that exist for relapsed/refractory Burkitt lymphoma, there is a need for the development of new therapies. This review aims to discuss evidence for current management strategies including chemotherapy and stem cell transplant, and highlight gaps in knowledge that will need to be addressed in the future.
ISSN:0956-4624
1758-1052
DOI:10.1177/0956462417748239